Playlist

National Tourist Zone “Avaza” is Ready to Host LLDC3 International Forum

25 Jul. 11:09

From August 4 to 8, 2025, the Third United Nations Conference on Landlocked Developing Countries (LLDC3) will be held in the National Tourist Zone “Avaza”. Turkmenistan, hosting such a significant event for the first time, is actively finalizing preparations for this high-level international forum.

The five-day event will encompass political, diplomatic, economic, cultural, and humanitarian dimensions. The conference agenda includes plenary sessions, thematic roundtables, and specialized forums focusing on the most pressing global issues, such as South-West regional cooperation, parliamentary dialogue, the role of civil society, youth engagement, and gender leadership.

In addition, the program features business meetings, thematic exhibitions, cultural events, and Central Asian Culture Days. A number of side events will be organized by international organizations, participating countries, and Turkmen representatives. Key topics will include land transportation, building international trust, youth policy, sustainable energy, and the circular economy.

Leaders from 32 countries, government representatives, UN member states, and heads of the organization are expected to attend. Also participating will be international organizations, members of parliament, financial institutions, civil society organizations, and private sector representatives. The forum aims to support landlocked developing countries in overcoming challenges, unlocking their potential, and creating new opportunities for development.

 

 

Annagul NAZAROVA,
2nd year student of the Faculty of International Journalism

of the Institute of International Relations

of the Ministry of Foreign Affairs of Turkmenistan

 

                                                                               

                                               

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds

Today in 02:02

Source

Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.

Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌